Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease
Open accessAbstract
Introduction: Quantitative EEG features have been identified as surrogates and predictors of cognitive decline/dementia, a common feature of progressive PD. The biochemical correlates for altered quantitative EEG features are unknown. Our primary objective was to test the hypothesis that quantitative EEG measures correlate with cortical levels of phosphorylated α‐synuclein, a modified form of the synaptic protein α‐synuclein, in PD cases, in contrast to other pathology‐associated proteins. A secondary objective was to explore the same correlations among cellular fractions of these proteins. Methods: We used posterior cingulate cortex autopsy tissue from 44 PD subjects with various degrees of cognitive decline, who had undergone EEG. In this brain region, which is a major hub of the default mode network, biochemical measurements for levels of phosphorylated α‐synuclein, unmodified α‐synuclein, amyloid beta peptide, phosphorylated tau, and key synaptic proteins were analyzed and data correlated with spectral EEG measures. Results: Findings revealed significant correlations between background rhythm peak frequency and all bandpower values (highest in delta bandpower) with total phosphorylated α‐synuclein, but not any correlation with total α‐synuclein, phosphorylated tau protein, amyloid beta peptide, or synaptic proteins. Certain fractions of synaptosomal‐associated protein 25 showed correlation with some quantitative EEG measures. Conclusions: These data show an association between increased phosphorylation of α‐synuclein and the abnormal EEG signatures of cognitive decline. Results suggest that quantitative EEG may provide an in vivo approximation of phosphorylated α‐synuclein in PD cortex. This adds to previous evidence that quantitative EEG measures can be considered valid biomarkers of PD cognitive decline. © 2016 International Parkinson and Movement Disorder Society
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
QEEG could reflect the amount of phosphorylated α-synuclein in the cortex of patients with PD.
“A study revealed that QEEG could reflect the amount of phosphorylated α-synuclein in the cortex of patients with PD [27].”
From QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis (2023) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,756 · see citing works
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027 · see citing works
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609 · see citing works
Self-citationThe role of the posterior cingulate cortex in cognition and disease
Leech, R., & Sharp, D. J. (2014) · Brain · doi:10.1093/brain/awt162 · Cited by 2,247 · see citing works
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 1,906 · see citing works
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,817 · see citing works
Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,418 · see citing works
Self-citationThe role of default network deactivation in cognition and disease
Anticevic, A., Cole, M. W., Murray, J. D., Corlett, P. R., Wang, X.-J., & Krystal, J. H. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.10.008 · Cited by 978 · see citing works
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · see citing works
Self-citationChen, L., & Feany, M. Β. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 614 · see citing works
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 521 · see citing works
Low clinical diagnostic accuracy of early vs advanced Parkinson disease
Adler, C. H., Beach, T. G., Hentz, J. G., Shill, H. A., Caviness, J. N., Driver‐Dunckley, E. D., Sabbagh, M. N., Sue, L. I., Jacobson, S. A., Belden, C. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000641 · Cited by 503 · see citing works
Self-citationBurré, J., Sharma, M., & Südhof, T. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416598111 · Cited by 478 · see citing works
Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460 · see citing works
Self-citationDefining mild cognitive impairment in Parkinson's disease
Caviness, J. N., Driver‐Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., Evidente, V. G. H., Shill, H. A., & Adler, C. H. (2007) · Movement Disorders · doi:10.1002/mds.21453 · Cited by 422 · see citing works
Self-citationEndoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo
Colla, E., Coune, P., Liu, Y., Pletniková, O., Troncoso, J. C., Iwatsubo, T., Schneider, B. L., & Lee, M. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5367-11.2012 · Cited by 389 · see citing works
The neurobiological basis of cognitive impairment in Parkinson's disease
Halliday, G. M., Leverenz, J. B., Schneider, J. S., & Adler, C. H. (2014) · Movement Disorders · doi:10.1002/mds.25857 · Cited by 366 · see citing works
Self-citationColla, E., Jensen, P. H., Pletniková, O., Troncoso, J. C., Glabe, C. G., & Lee, M. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5368-11.2012 · Cited by 324 · see citing works
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease
Garcia-Reitboeck, P., Anichtchik, O. V., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B. F., Corte, L., Spano, P., Tofaris, G. K., et al. (2010) · Brain · doi:10.1093/brain/awq132 · Cited by 293 · see citing works
Neuropathology of non-motor features of Parkinson disease
Dickson, D. W., Fujishiro, H., Orr, C., DelleDonne, A., Josephs, K. A., Frigerio, R., Burnett, M. S., Parisi, J. E., Klos, K. J., & Ahlskog, J. E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70769-2 · Cited by 267 · see citing works
Grey matter atrophy in cognitively impaired Parkinson's disease
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R. J., Dalrymple‐Alford, J. C., & Anderson, T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300828 · Cited by 244 · see citing works
Disrupted brain network topology in Parkinson’s disease: a longitudinal magnetoencephalography study
Dubbelink, K. T. E. O., Hillebrand, A., Stoffers, D., Deijen, J. B., Twisk, J. W. R., Stam, C. J., & Berendse, H. W. (2013) · Brain · doi:10.1093/brain/awt316 · Cited by 244 · see citing works
Quantitative EEG as a predictive biomarker for Parkinson disease dementia
Klassen, B. T., Hentz, J. G., Shill, H. A., Driver‐Dunckley, E. D., Evidente, V. G. H., Sabbagh, M. N., Adler, C. H., & Caviness, J. N. (2011) · Neurology · doi:10.1212/wnl.0b013e318224af8d · Cited by 215 · see citing works
Self-citationChen, L., Periquet, M., Wang, X., Negro, A., McLean, P. J., Hyman, B. T., & Feany, M. Β. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39088 · Cited by 213 · see citing works
Parkinson Disease With Dementia
Sabbagh, M. N., Adler, C. H., Lahti, T., Connor, D. J., Vedders, L. J., Peterson, L. K., Caviness, J. N., Shill, H. A., Sue, L. I., Ziabreva, I., et al. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31819c5ef4 · Cited by 209 · see citing works
Self-citationBiophysics of α-synuclein membrane interactions
Pfefferkorn, C. M., Jiang, Z., & Lee, J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.032 · Cited by 190 · see citing works
The default mode network is disrupted in parkinson's disease with visual hallucinations
Yao, N., Chang, R. S., Cheung, C., Pang, S. Y.-Y., Lau, K. K., John Suckling, A., Rowe, J. B., Yu, K., Mak, H. K., Chua, S.-E., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22577 · Cited by 151 · see citing works
Walker, D. G., Lue, L., Adler, C. H., Shill, H. A., Caviness, J. N., Sabbagh, M. N., Akiyama, H., Serrano, G. E., Sue, L. I., & Beach, T. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.020 · Cited by 150 · see citing works
Self-citationThe spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 142 · see citing works
α-Synuclein Oligomers: an Amyloid Pore?
Stöckl, M. T., Zijlstra, N., & Subramaniam, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8331-4 · Cited by 101 · see citing works
Swirski, M., Miners, J. S., de Silva, R., Lashley, T., Ling, H., Holton, J. L., Révész, T., & Love, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0077-y · Cited by 97 · see citing works
Longitudinal EEG Changes Correlate with Cognitive Measure Deterioration in Parkinson's Disease
Caviness, J. N., Hentz, J. G., Belden, C. M., Shill, H. A., Driver‐Dunckley, E. D., Sabbagh, M. N., Powell, J. J., & Adler, C. H. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-140480 · Cited by 94 · see citing works
Self-citationZaltieri, M., Longhena, F., Pizzi, M., Missale, C., Spano, P., & Bellucci, A. (2015) · Parkinson s Disease · doi:10.1155/2015/108029 · Cited by 92 · see citing works
Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 91 · see citing works
Dubbelink, K. T. E. O., Stoffers, D., Deijen, J. B., Twisk, J. W. R., Stam, C. J., Hillebrand, A., & Berendse, H. W. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.04.003 · Cited by 81 · see citing works
Franciotti, R., Pizzi, S. D., Perfetti, B., Tartaro, A., Bonanni, L., Thomas, A., Weis, L., Biundo, R., Antonini, A., & ONOFRJ, M. C. (2015) · Movement Disorders · doi:10.1002/mds.26285 · Cited by 79 · see citing works
Comparison of Quantitative EEGs Between Parkinson Disease and Age-Adjusted Normal Controls
Serizawa, K., Kamei, S., Morita, A., Hara, M., Mizutani, T., Yoshihashi, H., Yamaguchi, M., Takeshita, J., & Hirayanagi, K. (2008) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31818f50de · Cited by 74 · see citing works
Fantini, J., & Yahi, N. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_2 · Cited by 73 · see citing works
Lue, L., Walker, D. G., Adler, C., Shill, H. A., Tran, H., Akiyama, H., Sue, L., Caviness, J., Sabbagh, M. N., & Beach, T. G. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00585.x · Cited by 65 · see citing works
Self-citationDisbrow, E. A., Carmichael, O. T., He, J., Lanni, K. E., Dressler, E. M., Zhang, L., Malhado-Chang, N., & Sigvardt, K. A. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130341 · Cited by 62 · see citing works
Dementia, Mild Cognitive Impairment and Quantitative EEG in Patients with Parkinson's Disease
Fonseca, L. C., Tedrus, G. M. A. S., Letro, G. H., & Bossoni, A. S. (2009) · Clinical EEG and Neuroscience · doi:10.1177/155005940904000309 · Cited by 59 · see citing works
Bentea, E., der Perren, A. V., Liefferinge, J. V., Arfani, A. E., Albertini, G., Demuyser, T., Merckx, E., Michotte, Y. M., Smolders, I. J., Baekelandt, V., et al. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00068 · Cited by 53 · see citing works
Pathophysiology of Parkinson's disease behavior – a view from the network
Caviness, J. N. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70012-9 · Cited by 50 · see citing works
Self-citationBellucci, A., Navarria, L., Zaltieri, M., Missale, C., & Spano, P. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.031 · Cited by 48 · see citing works
Parkinson's Disease Dementia and Potential Therapeutic Strategies
Caviness, J. N., Lue, L., Adler, C. H., & Walker, D. G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00216.x · Cited by 46 · see citing works
Self-citationResting-State Networks in Alzheimer's Disease and Parkinson's Disease
Rektorová, I. (2013) · Neurodegenerative Diseases · doi:10.1159/000354237 · Cited by 38 · see citing works
Power spectra for screening parkinsonian patients for mild cognitive impairment
Bousleiman, H., Zimmermann, R., Ahmed, S., Hardmeier, M., Hatz, F., Schindler, C., Röth, V., Gschwandtner, U., & Fuhr, P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.129 · Cited by 29 · see citing works
Parkinson's disease, cortical dysfunction, and alpha‐synuclein
Caviness, J. N., Lue, L., Beach, T. G., Hentz, J. G., Adler, C. H., Sue, L. I., Sadeghi, R., Driver‐Dunckley, E. D., Evidente, V. G. H., Sabbagh, M. N., et al. (2011) · Movement Disorders · doi:10.1002/mds.23697 · Cited by 26 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Guner, D., Tiftikcioglu, B. I., Tuncay, N., & Zorlu, Y. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059416662412 · Cited by 33 · see citing works
Cai, M., Dang, G., Su, X., Zhu, L., Shi, X., Che, S., Lan, X., Luo, X., & Guo, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.701499 · Cited by 22 · see citing works
Liu, H., Huang, Z., Deng, B., Chang, Z., Yang, X., Guo, X., Yuan, F., Yang, Q., Wang, L., Zou, H., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0514 · Cited by 20 · see citing works
- Authors
- Caviness, J. N., Lue, L., Hentz, J. G., Schmitz, C. T., Adler, C. H., Shill, H. A., Sabbagh, M. N., Beach, T. G., & Walker, D. G.
- Affiliations
- Mayo Clinic (US)
- Banner Sun Health Research Institute (US)
- Corresponding author
- Caviness, John N.
- ORCID
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2016-04-08
- Volume
- 31
- Issue
- 7
- Pages
- 1012-1019
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- PMC
- PMC4931950
- OpenAlex
- W2337829485
- Cited by
- 37
- References
- 48
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 1 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 6 · 2016: 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- the National Institute of Neurological Disorders and Stroke (U24 NS072026)
- the National Institute on Aging ((P30 AG19610 Arizona Alzheimer's Disease Core Center))
- the Arizona Department of Health Services ((211002, Arizona Alzheimer's Research Center))
- the Arizona Biomedical Research Commission (4001, 0011, 05-901, and 1001)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- Parkinson's disease, phosphorylated alpha-synuclein, quantitative EEG, cognitive decline, posterior cingulate cortex, amyloid-beta, phosphorylated tau, SNAP-25, biomarkers, default mode network
- MeSH terms
- Aged, Aged, 80 and over, Female, Gyrus Cinguli, Humans, Male, Parkinson Disease, Phosphorylation, alpha-Synuclein, Brain Waves
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
